RSM logo
International Journal of STD & AIDS

Home Current issue Browse archive Alerts About the journal Feedback
 
Int J STD AIDS 2006;17:571-578
doi:10.1258/095646206778113131
© 2006 Royal Society of Medicine Press

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aldenhoven, M
Right arrow Articles by Sanders, C J G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Review

Therapeutic strategies for epidemic Kaposi's sarcoma

M Aldenhoven, N P Barlo and C J G Sanders

Department of Dermatology/Allergology, University Medical Centre, Heidelberglaan 100, 3584 CX Utrecht, Netherlands; Department of Dermatology/Allergology, University Medical Centre, Heidelberglaan 100, 3584 CX Utrecht, Netherlands; Department of Dermatology/Allergology, University Medical Centre, Heidelberglaan 100, 3584 CX Utrecht, Netherlands

Kaposi's sarcoma (KS) remains the most commonly diagnosed malignancy in HIV-infected patients, and is one of the AIDS-defining diagnoses. Several different therapeutic options are available, but the optimal therapy is still unclear. The incidence of KS has sharply declined since highly active antiretroviral therapy (HAART) became widely available, making HAART indispensable in the treatment of epidemic KS. HAART can be given alone or in combination with systemic and local therapy. Systemic therapy can be given in disseminated, progressive or symptomatic disease. Treatment options are interferon-{alpha} and chemotherapy including pegylated-liposomal anthracyclines and paclitaxel. For local disease, radiotherapy, intralesional chemotherapy or cryotherapy may be used. In resource-limited settings, intravenous vincristine, oral etoposide or intramuscular bleomycin may be feasible options. Other therapies, such as angiogenesis inhibitors, are under investigation in clinical trials.

Key Words: SARCOMA • KAPOSI • AIDS • THERAPEUTICS • THERAPY


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Units Symbols and Abbreviations Sixth edition